Correlation of Hyperhomocysteinaemia and Chlamydia Pneumoniae IgG Seropositivity with Coronary Artery Disease in a General Population

Heart Lung and Circulation

Volumn 16, Issue 6, 2007, Pages 416-422

  Nabipour, Iraj ^a   Vahdat, Katayon ^a   Jafari, Seyed Mojtaba ^a   Amiri, Mohammad ^a   Shafeiae, Ebrahim ^a   Riazi, Ahmad ^a   Amini, Abdol Latif ^a   Pazoki, Raha ^a   Sanjdideh, Zahra ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Chlamydia pneumoniae; Coronary artery disease; Hyperhomocysteinaemia

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; IMMUNOGLOBULIN G ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; BODY MASS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; COVARIANCE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; RISK MANAGEMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COHORT STUDIES; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; IMMUNOGLOBULIN G; INFORMATION SYSTEMS; MALE; MIDDLE AGED;

EID: 36048963963     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.02.100     Document Type: Article

References (35)

1. Fonseca V., Guba S.C., and Fink L.M. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocrine Rev 20 (1999) 738-759
2. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med 49 (1998) 31-62
3. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Eng J Med 338 (1998) 1042-1050
4. Hoogeveen E.K., Kostense P.J., Beks P.J., Macckaay A.J., Jakobs C., Boutr L.M., Heine R.J., and Stehouwer C.D. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 18 (1998) 133-138
5. Hoogeveen E.K., Kostense P.J., Jakobs C., Dekher J.M., Nijpels G., Heine R.J., Bouter L.M., and Stehouwer C.D. Hyperhomocysteinemia increase risk of death, especially in type 2 diabetes: 5 year follow-up of the Hoorn Study. Circulation 101 (2000) 1506-1511
6. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
7. Eikelboom J.W., Lonn E., Genest J.J.R., Hankey G., and Yusufo S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131 (1999) 363-375
8. Danesh J., Collins R., and Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
9. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Victor A., Hafner G., Prellwitz W., Schlumberger W., and Meyer J. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105 (2002) 15-21
10. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., and Valtonen V. Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 (1988) 983-986
11. Ngeh J., Anand V., and Gupta S. Chlamydia pneumoniae and atherosclerosis: what we know and what we don't. Clin Microbiol Infect 8 (2002) 2-13
12. Ramirez J.A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: the Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 125 (1996) 979-982
13. Wiesli P., Maly F.E., Meniconi A., Czerwenka W., Hoffmann U., Vetter W., and Schulthess G. Chlamydia pneumoniae seropositivity and hyperhomocysteinemia are linked in patients with atherosclerosis. Clin Chem 47 (2001) 1304-1306
14. Stanger O.H., Semmelrock H.J., Rehak P., Tiran B., Meinitzer A., Rigler B., and Tiran A. Hyperhomocysteinemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease. Atherosclerosis 162 (2002) 157-162
15. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
16. Prineas R.J., Crowe R.S., and Blackburn H. The Minnesota Code manual of electrocardiographic findings (1982), John Wright, Bristol
17. Langman L.J., and Cole D.E.C. Homocysteine: cholesterol of the 90s?. Clin Chim Acta 286 (1999) 63-80
18. Roivainen M., Viik-Kajander M., Palosuo T., Toivanen P., Leinonen M., Saikku P., Tenkanen L., Manninen V., Hovi T., and Manttari M. Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (2000) 252-257
19. Dechend R., Maass M., Gieffers J., Dietz R., Scheidereit C., Leutz A., and Gulba D.C. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100 (1999) 1369-1373
20. Rodel J., Woytas M., Groh A., Schmidt K.H., Hartmann M., Lehmann M., and Straube E. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 68 (2000) 3635-3641
21. Kol A., Sukhova G.K., Lichtman A.H., and Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98 (1998) 300-307
22. Vehmaan-Kreula P., Puolakkainen M., Sarvas M., Welqus H.G., and Kovanen P.T. Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 21 (2001) E1-E8
23. Shapiro S.D., Kobayashi D.K., and Ley T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 268 (1993) 23824-23924
24. Bescond A., Augier T., Chareyre C., Garcon D., Hornebeck W., and Charpiot P. Influence of homocysteine on matrix metalloproteinase-2: activation and activity. Biochem Biophys Res Commun 263 (1999) 498-503
25. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., and Wissler R.W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
26. Arno G., Kaski J.C., Smith D.A., Akiyu J.P., Hughes S.E., and Baboonian C. Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart 91 (2005) 521-525
27. Guo H., Lee J.D., Uzui H., Uzui H., Xing Y., Wang J., Toyoda K., Geshi T., and Ueda T. Effect of erythromycin on homocysteine-induced extracellular matrix metalloproteinase-2 production in cultured rat vascular smooth muscle cells. Indian J Med Res 121 (2005) 764-770
28. Schulthess G., Wiesli P., and Maly F.E. Macrolide treatment dose not influence serum homocysteine in Chlamydia pneumoniae-seropositive patients suffering from atherosclerosis. Clin Chem 48 (2002) 1631
29. Kuo C.C., and Grayston J.T. Amino acid requirements for growth of Chlamydia pneumoniae in cell cultures: growth enhancement by lysine or methionine depletion. J Clin Microbiol 28 (1990) 1098-1100
30. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., and Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii (1988) 983-986
31. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Wong Y., Bernardes-Silva M., and Ward M. Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis. BMJ 321 (2000) 208-213
32. Danesh J., Whincup P., Lewington S., Walker M., Lennon L., Thomson A., Wong Y.K., Zhou X., and Ward M. Chlamydia pneumonia IgA titers and coronary heart disease; prospective study and meta-analysis. Eur Heart J 23 (2002) 371-375
33. Christen W.G., Ajani U.A., Glynn R.J., and Hennekens C.H. Blood levels of homocysteine and increased risks of cardiovascular disease. Arch Intern Med 160 (2000) 422-434
34. De Bacquer D., De Backer G., Kornitzer M., Myny K., Doyen Z., and Blackburn H. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. J Am Coll Cardiol 32 (1998) 680-685
35. Crow R.S., Prineas R.J., Hannan P.J., Grandits G., and Blackburn H. Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 80 (1997) 138-144